Purchase of Antineoplastic and Immunomodulating Agents AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Object of the Procurement

  • What is being procured: Medicines with the active substance daratumumab.
  • Main technical requirements, characteristics:
    • The offered medicines must have valid marketing authorizations (registered in the medicine register).
    • The expiry date at the time of delivery must be at least 70% of the product’s initial shelf life.
    • Goods must be delivered in manufacturer’s original packaging (if the order matches the number of original manufacturer’s packages).
      *…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

301346_ESPD_v2.0_laiendatud.xml

301346_hankepass_taiendavate_selgitustega.pdf

301346_hindamiskriteeriumid.pdf

301346_vastavustingimused.pdf

301346.zip

RH 301346 HD Lisa 1_ravimi kirjeldus.xlsx

RH 301346 HD Lisa 2_lepingu projekt.pdf

RH 301346 HD ravimid.pdf

Ready to get started?

Subscribe and enjoy all the benefits every day!